Previous Meetings

2023 Meeting

Leuven, Belgium

2022 Virtual Meeting

2021 Virtual Meeting

Thursday, September 30 - Saturday, October 2

Preconference Workshop:

Dr. Marta Walentynowicz

Ecological Momentary Assessment

Invited Keynote Speaker:

Dr. Ronald Teufel

Using Technology to Collect Meaningful Patient Level Information such as Ecological Momentary Assessment Symptoms and Adherence in Asthma and COPD

2020 Virtual Meeting

September 11, 2020

2020 Meeting Program can be found here.

Invited Keynote Speakers:

Prof. Dr. Charles Agyemang, MPH, PhD

Black Lives Matter Invited Talk: Impact of COVID-19 pandemic on ethnic minority and migrant population

Prof. Charles Agyemang is a Professor of Global Migration, Ethnicity and Health at Amsterdam University Medical Centres, University of Amsterdam, The Netherlands. His research is focused on ethnicity, migration and health and NCDs in low- and middle-income countries. He is the PI of the RODAM Study http://www.rod-am.eu/.

Prof. Agyemang is a fellow of the prestigious European Research Council (ERC) under the Consolidation Award programme; and is currently the Vice President of the Migrant Health section of the European Public health Association.

He is an Associate Editor for Internal and Emergency Medicine and International Journal of Hypertension, and serves as an Editorial Board member for several journals. He was member of the WHO taskforce on NCDs in Migrants and also as a member and rapporteur of the Planning Committee for WHO Global Consultation on Migrant Health.

Prof. Agyemang has authored/co-authored over 280 published papers, and edited several books.

Prof. Dr. Thomas Ritz, PhD

COVID-19 Invited Talk: Airway Nitric Oxide and Respiratory Infections: Considerations for Times of A Global Pandemic

Dr. Thomas Ritz is Professor of Psychology at Southern Methodist University. He is Director of the Psychobiology of Emotion, Stress, and Chronic Disease Research Program and organizer of the Biopsychosocial Research Cluster of the Dedman College Interdisciplinary Institute. His research of the past 25+ years has focused on the psychobiology and psychosomatic medicine of respiratory disease and comorbid affective disorders. Much of his work is interdisciplinary with colleagues in biology, chemistry, and medicine, with an emphasis on consolidating a basic research foundation for treatment and translating basic findings into psychological, behavioral, and life-style interventions for respiratory diseases. His research has been supported by federal funding agencies and private foundations in the US, Germany, Canada, and the UK. He attended his first ISARP meeting in 1995 and was president of ISARP in 2003.

2019 Meeting

October 4-6
Vevey, Switzerland

Program

Meeting 2019 Program

Keynote Speakers

Prof. Dr. Christina Spengler, Ph.D.

Head of the Exercise Physiology Lab, ETH Zurich, Switzerland

Deputy Head of the Institute of Human Movement Sciences and Sport, ETH Zurich, Switzerland

Dr. Justin Feinstein, Ph.D. “Searching for the source of suffocation false alarms in the human brain”

Dr. Justin Feinstein is a Clinical Neuropsychologist at the Laureate Institute for Brain Research and an Associate Professor in the Oxley College of Health Sciences at the University of Tulsa. Utilizing both the lesion method and functional neuroimaging, his laboratory investigates how the human brain produces primal states of emotion, with an emphasis on the neuroscience of fear and treatments that alleviate anxiety.  Dr. Feinstein joined the faculty of the Laureate Institute for Brain Research and the University of Tulsa in 2013, after completing his Ph.D. at the University of Iowa, and his postdoctoral fellowship at the California Institute of Technology.  He earned his undergraduate degree in Cognitive Neuroscience at the University of California, San Diego, and completed his clinical internship at the San Diego VA hospital with a focus on the treatment of veterans with PTSD using Prolonged Exposure therapy.  His research has been published in a number of top scientific journals and has been featured in the popular press including the New York Times, TIME magazine, and the New Scientist.

Dr. Bruce Miller, MD “Where Asthma Fits in Respiratory Psychophysiology: An Inverse Translational Approach”

Bruce D. Miller, M.D. is Professor of Psychiatry and Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo. Dr. Miller is a pediatric psychiatrist and researcher focusing on psychophysiological pathways and mechanisms by which stress and emotions influence asthma in children. He has an established laboratory-based research program supported by NIH funding, and has authored more than 50 peer reviewed papers, chapters and review articles on topics relevant to the mind-body interface. He has presented nationally and internationally on these topics. The American Academy of Child and Adolescent Psychiatry recognized his contributions to Pediatric Psychiatry by naming him the 2004 recipient of the Simon Wile Leadership Award for distinguished career achievement in the field of pediatric consultation-liaison psychiatry. In 2010 he was invited to present the 10th Annual Golden Lectureship on Mind-Body Medicine at UB . Dr. Miller’s basic research training is in developmental psychobiology. After his post-doctoral Research Fellowship in Developmental Psychobiology in the Department of Psychiatry, University of Colorado Health Sciences Center, he developed the Psychophysiologic Treatment/Research Unit at National Jewish Medical and Research Center (now called National Jewish Health) to continue and expand this line of research.  At this unit Dr. Miler laid the foundation for the study and treatment of medically vulnerable and high risk asthmatic children who were mostly from minority low income families. Dr. Miller has been involved in federally funded research since 1979 focusing on psychobiologic mechanisms by which stress and depression influence pediatric asthma. In 1986-87, Dr. Miller served as an invited member of the AAAI/NHLBI Asthma Mortality Task Force, whose goal was to set priorities for research aimed at reducing asthma mortality. This task force identified low SES, minority children as high risk and recommended prioritizing research in this population. These experiences, alongside of his clinical background in psychiatry and pediatrics, prepared him to serve as Principle Investigator in the systematic investigation of mechanisms and pathways by which stress and depression effect physiologic and immune processes in high risk, asthmatic children

2018 Meeting

October 12-14
Gainsville, FL

Program

Meeting 2018 Program

Keynote Speakers

Gordon S. Mitchell received his PhD in Developmental and Cell Biology from the University of California at Irvine in 1978, followed by postdoctoral work at the Max Planck Institute for Experimental Medicine in Göttingen, Germany (with Peter Scheid) and the University of Wisconsin-Madison (with Jerome Dempsey). He became a faculty member at the University of Wisconsin in 1981, progressing to full professor in 1992; he served as department Chair for 17 years before leaving to join the University of Florida as a Preeminence Professor of Neuroscience in the Department of Physical Therapy. There he created and serves as director of the UF Center for Respiratory Research and Rehabilitation. Dr. Mitchell has received numerous research awards, including a MERIT Award from the National Institutes of Health, is a Fellow of the American Physiological Society, and was the UW Steenbock Professor in Behavioral and Neural Science. He has delivered multiple award lectures including: Society for Neuroscience Special Lecturer (2008), Julius H. Comroe Distinguished Lecturer (American Physiological Society, 2014), Guyton Distinguished Lectureship (Association of Chairs of Departments of Physiology, 2014). He has recently delivered plenary/keynote lectures at the Oxford Conference for Modeling and the Control of Breathing (2017), Society for Experimental Biology (2014), International Union of Physiological Sciences (2014), Experimental Biology (2015), Veterinary Comparative Respiratory Society (2016), ASIA (2017), and Canadian Spinal Cord Injury Rehabilitation Association (2017). His research concerns (cellular and network) mechanisms of respiratory and non-respiratory motor plasticity, particularly spinal plasticity induced by intermittent hypoxia. He applies that knowledge to develop novel therapeutic strategies for spinal injury, motor neuron disease and other clinical disorders that compromise movement. 

Kevin P. Fennelly, MD, MPH, ATSF,  is currently a Senior Research Clinician in the Laboratory of Chronic Airway Infection in the Pulmonary Branch, Division of Intramural Research in the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, MD.  After receiving his medical degree from the University of Vermont, he completed a residency in Internal Medicine at the University of California, San Francisco (UCSF).  He was then the first fellow in the UCSF combined pulmonary-occupational/environmental medicine fellowship, which included completing his Master’s in Public Health degree at UC Berkeley.  As a junior faculty member at National Jewish Medical & Research Center in Denver, he and colleagues were the first to recognize irritant-associated vocal cord dysfunction (VCD).  He also became interested in personal respiratory protection of health care workers against tuberculosis (TB). This led to his research in developing the first successful studies to collect, quantify, and size the infectious aerosols generated by coughing from patients with active TB.   Subsequent studies done in Uganda have shown that cough aerosols from TB patients are the best predictors of transmission to household contacts.  Dr. Fennelly was recruited to the University of Florida in 2010 where he developed a Nontuberculous Mycobacterial (NTM) Disease Clinical Research Program.   His group was the first to demonstrate the presence of mycobacterial biofilm in a lung cavity of a patient.  He also led an effort to study cough in patients with NTM disease, which he will discuss at this conference.   In 2015 he was recruited to the NIH Clinical Center, where he and colleagues are conducting clinical research in bronchiectasis and nontuberculous mycobacterial infections, and he has continued to collaborate on TB studies.  Dr. Fennelly is very active in the American Thoracic Society, where he recently served as the Chair for the Assembly on Pulmonary Infections and TB.   

Jessica E. Huber, PH.D., CCC-SLP, is a Professor of Speech, Language, and Hearing Sciences and Associate Vice Provost for Faculty Affairs at Purdue University. The aim of her NIH funded research program is to develop a theoretical account of the multiple factors that influence speech production and cognitive change in older adults with and without Parkinson’s disease (PD) and to translate findings to clinical treatment resulting in improvements in communication.  She is the inventor of a small wearable device, the SpeechVive device, to treat communication impairments in people with PD. The device elicits the Lombard effect that can be exploited to improve speech clarity in individuals with PD while bypassing cognitive and sensory impairments. Her current research continues to examine the physiologic (respiratory, laryngeal, and supralaryngeal) effects a number of speech therapy techniques including respiratory muscle strength training and using the SpeechVive device.

2017 Meeting

September 15 - 17
Lille, France

Program

Meeting 2017 Program

Keynote Speakers

Prof. Thomas Similowski was born in 1961. He is married to Kathy, and they have 4 children Laura, Paul, Elsa, Clara. He is Professor of Respiratory Medicine at "Faculté de Médecine Pitié-Salpêtrière, Université Paris 6 Pierre et Marie Curie", Paris, France and is the head of the "Department of Respiratory and Intensive Care Medicine, Pulmonary Rehabilitation and Sleep Medicine" within the "Groupe Hospitalier Pitié-Salpêtrière Charles Foix", Paris, France, one of the largest European hospitals.

The clinical activity of the department is devoted to acute respiratory care on one hand, and to the management of respiratory handicap on the other hand. All forms and sources of respiratory handicap are considered, from severe COPD to the respiratory impact of neurological and neuromuscular diseases, with emphasis on amyotrophic lateral sclerosis and quadriplegia (the department is the only center for diaphragm pacing in France).

In the field of research, Prof. Similowski is the head of research unit UMRS 1158 "Clinical and Experimental Respiratory Neurophysiology" of INSERM and Université Paris 6 Pierre et Marie Curie. This translational unit comprises an animal laboratory and a human laboraory, and uses many techniques from molecular biology to psychophysiology, and including electrophysiology, functional imaging, and mathematical modelling. The unit is entirely devoted to the study of the interactions between the respiratory system and the nervous system. This goes from the study of respiratory muscle function in health and diseases to the study of the mechanisms of breathing control, with emphasis on the relationship between the cerebral cortex and breathing and the pathophysiology and psychophysiology of dyspnea.    

From a personal point of view, Prof. Similowski is a former research fellow of the Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada. He has published more that 300 peer-reviewed articles. In 2000, he was awarded the Cournand lecture of the European Respiratory Society. In 2004, he received a French "Victoire de la Médecine" for implementing diaphragm pacing in France. In 2015, he received the "Prix François Petay pour la recherche sur la BPCO" from the prestigious French "Fondation pour la Recherche Médicale", and in 2016 he was elected Fellow of the European Respiratory Society. 

Prof. Hilary Pinnock is Professor of Primary Care Respiratory Medicine with the Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, University of Edinburgh, and a general practitioner in Whitstable, Kent.

Her research interests include the delivery of care within the ‘real-life’ primary care setting including implementing self-management for asthma, telehealthcare for supporting management of respiratory disease, supporting people with COPD and depression to attend pulmonary rehabilitation, and supportive care for people with severe COPD.

She leads the education subgroup of the International Primary Care Respiratory Group, and chairs the primary care group of the European Respiratory Society.  She chairs the self-management and diagnosis evidence review groups of the BTS/SIGN asthma guideline and is an education editor of npjPrimary Care Respiratory Medicine.

2016 Meeting

October 7 - 9

Seattle Children’s Research Institute, Seattle

Program

Meeting 2016 Program

Keynote Speakers

Dr.  Jeannette D. Hoit
Professor, University of Arizona

Dr. Hoit is a professor in Speech, Language, and Hearing Sciences, and a member of the Program in Neuroscience faculty, Motor Control Training faculty, and National Center for Neurogenic Communication Disorders faculty. She received her Ph.D. in Speech and Hearing Sciences from the University of Arizona in 1986 and later pursued postdoctoral study in the Respiratory Biology Program, Harvard School of Public Health, and the Speech Research Laboratory, Massachusetts Institute of Technology. Dr. Hoit’s research and teaching interests include speech physiology as it relates to normal processes, particularly development and aging, and abnormal processes, particularly those associated with neuromotor speech disorders. She is currently focusing her research efforts on the areas of ventilator-supported speech and speaking-related dyspnea.

Dr. Bradley J. Undem
Professor, The Johns Hopkins School of Medicine

Dr. Undem received his Ph.D. in Pharmacology from University of Wisconsin in 1985.  After post-doctoral training in Immunology at Johns Hopkins, he was appointed to Assistant Professor in 1987.  In 1997 he was appointed to his present position of Full Professor in the Department of Medicine with a Joint Appointments in The Center for Sensory Biology in the Department of Molecular Medicine, and in the department of Respiratory Physiology at the Bloomberg School of Public Health.  Dr. Undem has published extensively on the role of airway sensory and autonomic nerves in health and disease.   He has mentored over 25 graduate students and post-doctoral fellows, has served on the editorial board for 11 journals, and is a frequent peer reviewer for The National Institutes of Health and various international funding agencies.

2015 Meeting

October 9 - 11

Seville, Spain

Program

Meeting 2015 Program

Invited Speakers

We are honored to host a distinguished panel of invited speakers who contribute to the study of psychological and behavioral factors in respiration from a variety of perspectives.

Richard Kinkead, Ph.D., is a Professor at the Department of Pediatrics of Laval University, Québec, in Canada, supported by a Canada Research Chair in Respiratory Neurobiology. He has worked on animal models of neonatal maternal separation stress and neuroendocrine programming of the respiratory control system, providing important contributions to our understanding of the maturation and plasticity of the central nervous system regulation of ventilation. His work also provides important insights into early-life risk factors for panic and anxiety disorders.

Kyle T.S. Pattinson, BM DPhil FRCA, is a Consultant Anesthetist and Associate Professor at the Nuffield Department of Clinical Neurosciences, Oxford University, UK. He has worked extensively on the central nervous system regulation of respiratory control and has used the latest functional magnetic resonance imaging techniques to elucidate pathways and functional subdivisions of control centers. Other aspects of his research include imaging of brain perfusion changes following aneurysmal subarachnoid hemorrhage and respiratory adaptation to high altitude. His work has been published in leading peer-reviewed journals of neuroscience and physiology.

Jose Luis Lopez-Campos, M.D., is an Associate Professor of Medicine at Seville University and a Pulmonologist at Virgen del Rocio University Hospital in Seville, Spain where he is in charge of the specialized Chronic Obstructive Pulmonary Disease outpatient clinic. He has worked extensively on various aspects of clinical care for COPD patients, including the organization of pulmonary rehabilitation and assessment of patients’ perception of dyspnea and disease status. His work has been associated with large-scale national and European research collaborations and guideline initiatives. At the ISARP meeting, he will present a keynote address on "The importance of patient's perception in COPD assessment". 

2014 Meeting

New Brunswick, New Jersey

September 19 – 21

Program

Meeting 2014 Program

Invited Speakers

We will have two exciting invited presentations at the upcoming conference, on Saturday and Sunday: Drs. Charles Irvin and Nancy Fiedler. On Friday evening, in addition to our welcome reception, program host Dr. Paul Lehrer will present an overview of his 40 year psychophysiology research career at Rutgers.

Charles Irvin, PhD is Professor of Medicine, Molecular Physiology, and Biophysics at the University of Vermont, after serving many years as head of the pulmonary laboratory at National Jewish Health (Denver, CO). A world renowned expert on asthma, pulmonary physiology, and animal models of lung disease, he has authored many of the accepted manuals for assessment of pulmonary function, and has played a central role in many of the large multicenter asthma trials. Dr. Irvin is the recipient of numerous research grants and has authored or co-authored over two hundred papers. In 2004, he received the Joseph R. Rodarte Award for Scientific Distinction from the American Thoracic Society.

Nancy Fiedler, PhD is Professor of Environmental and Occupational Medicine at Rutgers University, Robert Wood Johnson Medical School. She has published prolifically on behavioral and physiological effects of exposure to various environmental toxins, the psychophysiology of symptom perception, and the influence of psychological stress to these processes. Dr. Feidler has received grant funding from a variety of Federal and International agencies.

Dr. Fiedler's presentation at the ISARP 2014 conference will be "Psychological and physiological effects of exposure to inhaled environmental toxins and irritants."